Background: A subset of children with perinatal HIV (pHIV) experience long-term
Introduction
A subset of children with perinatal-acquired human immunodeficiency virus (pHIV) exhibit neurocognitive difficulties [1] [2] despite use of antiretroviral therapy (ART) [3] . Initial findings from a prospective investigation of newborns with pHIV [4] described better neurocognitive outcomes at age 1 when ART was started within the first 30 days of life.
However, recent analyses indicate that the neurocognitive advantages attributed to initiation of ART during the immediate postnatal period are not sustained for many individuals in later childhood [5] . Similar findings have been reported in separate cohorts of older children with pHIV who initiated suppressive ART within weeks of birth [6] [7] , as well as subgroups of children who initiated ART after surviving the first year of life without significant immune compromise [8] [9] [10] [11] [12] [13] .
Predictive models of neurocognitive outcomes in children with pHIV remain elusive, especially for individuals residing in resource-restricted environments where most of the global population of children with pHIV reside. Traditional data analytic methods are not well suited to discover mechanisms that underlie complex clinical phenotypes such as neurocognitive development [see 14 for review]. Common statistical models are inherently restricted by statistical assumptions (e.g., normality), redundancy across variables (e.g., multicollinearity), and reliance on conservative significance thresholds to reduce errors resulting from multiple comparisons [14] . Additionally, traditional methods, such as logistic regression, require a priori selection of predictor variables despite limited insights into the underlying data structure [14] .
This approach is appropriate for confirmation testing, but highly punitive for work aimed at scientific discovery.
Advanced data science methods such as machine learning offer a promising alternative to detect latent variables that underlie complex clinical phenotypes such as HIV [14] [15] [16] [17] [18] [19] [20] [21] . In studies of structural neuroimaging, Wade et al. [19] achieved 72% accuracy classifying adults as either HIV-infected or HIV-uninfected, and Zhang et al. [20] achieved 85% accuracy discriminating older adults with HIV from age-matched adults with early Alzheimer's disease. Most recently, Ogishi et al. [21] trained a classifier using viral signatures to identify adults with clinicallydefined severe neurocognitive impairment (HAD) versus individuals with no neurocognitive impairment. In this study, supervised machine learning achieved 90% predictive accuracy.
The studies above utilize cross-sectional data to develop a data-driven algorithm for group classification. Only one study [21] examined utilized advanced methods to explore the underlying mechanisms, but the study solely focused on viral signatures. No studies have integrated demographic, HIV disease variables, routine laboratory indices, and psychosocial variables to establish a robust predictive algorithm for neurocognitive sequelae of HIV. Further, no studies have leveraged the methodological advantages of machine learning to establish a datadriven classifier of neurocognitive outcomes in children with pHIV. This represents an important gap in the literature considering that pediatric populations are likely to benefit from evidencebased methods to enrich neurocognitive outcomes.
The current study provides a foundation to address this gap in the literature. We used unsupervised machine learning to explore intrinsic patterns of bio-behavioral data within a large, high dimensional longitudinal dataset of 285 children with pHIV from Thailand and Cambodia [8] [9] . Here we leveraged the computational strengths of supervised machine learning to establish a data-driven algorithm of neurocognitive risk versus resilience among children with pHIV, and to discover novel predictors of neurocognitive risk stratification using common clinical measures.
Methods

Study Design
Archival data were analyzed from 285 Thai (n=170) and Cambodian (n=115) youth with pHIV enrolled in the Pediatric Randomized to Early vs. Deferred Initiation in Cambodia and Thailand (PREDICT) clinical trial (clinicaltrials.gov identification: U19AI53741) [8] [9] .
Enrollment for PREDICT began in 2006, before global treatment guidelines recommended ART at the time of diagnosis. The PREDICT study enrolled children with pHIV with CD4 % between 15-25% and no history of ART. Participants were then randomized to start ART immediately or when CD4 declined to 15%. Mortality and the frequency of AIDS-defining illnesses were evaluated 144 weeks from the date of enrollment. A neuro substudy began one year after the start of the main PREDICT trial (MH#). Published outcomes report no differences in survival, AIDSdefining illnesses, or neurocognitive outcomes between the two treatment arms [8] [9] [10] [11] [12] [13] . Most participants enrolled in PREDICT subsequently enrolled in an observational follow-up investigation (RESILIENCE; MH#
).
The present study included children ages 2-14 years at the time of the first neurocognitive assessment (consistent with the minimum age requirement for the primary outcome measure described below [22] . Performance is strongly related to chronological age [22] [23] ;
longitudinal studies of normative samples reveal an average increase in the total score of about 15 points from age 2 to age 20 years [23] . The BVMI was administered at enrollment (baseline), twice per year during the PREDICT trial, and then annually thereafter. The average duration of follow-up for the current analysis was 5.4 years.
Neurocognitive trajectories on the BVMI were quantified as the average percent change in raw score performance from baseline to the final test visit (i.e., positive vs. negative slopes) using all available performance data. Participants were designated as neurocognitively resilient (blue trajectories: n=145) or at-risk (red trajectories: n=140) based on a within sample comparison (upper/lower halves of the sample distribution; Figure 1 ). This binary designation optimized the number of observations to train the machine learning classifier while minimizing potential bias associated with various definitions of clinically-relevant neurocognitive impairment.
Candidate predictors of neurocognitive development
The major categories of candidate predictors (i.e., input features) included: 1)
demographic variables (age, sex, family income, etc.); 2) HIV disease indices (blood-derived CD4 T cell count, CD8 T cell count, viral load, etc.); 3) routine blood markers (complete blood count, glucose levels, triglycerides, etc.); and 4) emotional health indices (component and domain scales from the Child Behavior Checklist-Caregiver version (CBCL) [24] . Caregivers of participants completed age-appropriate versions of the CBCL (age 2 to 5 years or age 6 years and over), translated into Thai and Khmer. Raw scores were converted to standardized scores (T scores) to allow comparison to published studies in this population [8] [9] [10] [11] [12] [13] .
Machine learning approach
Our predictive algorithm was built using gradient boosted multivariate regression (GBM), a form of machine learning. GBM is based on random forest decision tree analysis, which utilizes recursive partitioning to iteratively populate homogeneous predictors [25] . The final output from the decision tree is represented mathematically as the lowest possible sum of squares. We set the default number of decision trees at 10,000 and shrinkage at 0.005. Prediction accuracy was calculated by transforming the raw output into a probability score using the sigmoid function (1/(1+e^(-x)). The assigned class label employed a 0.5 decision boundary for evaluation. Gradient descent was applied to minimize prediction errors. Performance indicators included the area under the curve (AUC), sensitivity, specificity, and the F1 score (i.e., harmonic balance between sensitivity and specificity). Calculations for these indices are described in detail elsewhere [26] . AUC interpretation followed standard convention (poor =<0.6, fair =0.7, good =0.8; excellent >0.8) [26] . Stability of the final model was examined using 5-fold crossvalidation.
Machine learning feature selection
The machine learning analysis was conducted in Python. Feature selection was conducted using an in-house program based on SciKit [27] and PDPBox [28] . Synthetic data elements (e.g., participant identification number) were not included in the machine learning analysis but all biologically plausible variables were examined without a priori bias related to predictive relevance. For each predictive variable, we considered multiple permutations of central tendency (e.g., average, max value), dispersion (e.g., standard deviation, percent variability) and change over time (e.g., average value per day, minimum percent change per day). Polynomial interactions were explored up to 3-way interactions. We selected 3-levels based on prior studies demonstrating 3-way interactions between environmental factors, biometrics, and psychosocial indices [29] . For behavioral inputs, feature clusters included both composite and subscale components (e.g., CBCL Total Score and CBCL Affective scale score) if the combination improved classification accuracy (i.e., the variables were not duplicative inputs).
Post-hoc analysis of data-driven predictors
The top 25 predictors of neurocognitive risk vs. resilience were compared using R. Mean values from the first and last visits were contrasted using Kruskal-Wallis test (p < 0.05), adjusted for multiple comparisons. Additionally, we conducted a standard logistic regression in R to establish a benchmark using traditional statistical analyses. In accord with standard convention, the maximum number of independent variables in the logistic regression was governed by the sample size, allowing for a total of 16 variables (four independent variables and each of the twoway interactions; all from baseline). The four independent variables included average family income, CD4/CD8 T-cell ratio, HIV viral load, and CBCL Total Score. These variables represented demographic, immunological, disease severity, and emotional health indices, respectively. The logistic regression was modeled using mean values versus indices informed by the machine learning results. This approach provided an opportunity to compare the results of machine learning to a traditional logistic regression. Fisher's Exact test [30] examined the classification accuracy obtained by logistic regression and the GBM.
Results
Demographic and clinical variables
At baseline, 157 (55%) participants were prescribed ART. First-line treatment included zidovudine, lamivudine, and nevirapine. One individual was diagnosed with esophageal candidiasis within the first month of enrollment; no other AIDS-defining illnesses were observed in either treatment arm. Between the time period of enrollment and the last neurocognitive assessment, 124 (43%) participants randomized to the deferred treatment arm exhibited a decline in CD4% that met threshold for ART initiation (i.e., < 15%). These individuals immediately began ART. The remaining 33 (11%) children did not experience a decline in CD4 T cell count < 15% before the final BVMI assessment; these participants remained untreated throughout the follow-up period included in the current analysis.
Machine learning classification results
The GBM classifier of neurocognitive trajectories achieved high accuracy (93%), with Table 2 for contrasts between groups on the top 10 features.
Posthoc logistic regression
The traditional logistic regression analysis using a subset of candidate predictors was nonsignificant (45% (X 2 (10) = 44.6, log likelihood: 175.20; pseudo R 2 : 0.11; Table S2 ). Total classification accuracy was 45% (compared to 93% using the machine learning approach).
Variables retained in the final logistic regression model included two interaction terms: 1) HIV viral load and CBCL Total Score; and 2) HIV viral load and family income. The difference in classification accuracy between the GBM algorithm (93%) and the logistic regression model (45%) was statistically significant (p =0.035; Fisher's Exact test).
Conclusions
Using supervised machine learning and intelligent feature creation and selection on highly dimensional data repository, we established a robust classifier of divergent neurocognitive trajectories in children with pHIV. The classifier yielded an average accuracy of group membership that was more than two times better than results obtained using standard logistic regression. Importantly, the machine learning method identified novel risk factors for suboptimal neurocognitive outcomes in this cohort of youth with pHIV, including numerous multi-level interactions between mental health and biological indices. The final classification algorithm was comprised of 25 predictive features derived from 54 data elements. The study is the first to integrate a large number of relevant risk factors to establish a predictive algorithm for neurocognitive outcomes in children with pHIV residing in resource-restricted environments.
Study findings demonstrate the potential for data-driven methods to generate new insights into the underlying mechanisms associated with divergent neurocognitive outcomes in children with pHIV.
Prior investigations aimed at unraveling the neuropathogenic model of pHIV have often leaned on the adult literature to select candidate mechanisms. This approach assumes that neurocognitive symptoms in pediatric and adult populations result from the same underlying processes. However, the scientific basis for this assumption is weak. Children with pHIV are typically infected in utero, when the brain is undergoing rapid, dynamic changes in neuronal architecture and functional organization [31] [32] [33] [34] . After birth, environmental pressures, including living with a chronic medical disease, moderate brain development and expression of brainbehavior phenotypes [35] [36] [37] [38] . Many children infected with HIV also face chronic stress associated with poverty (food security and malnutrition, limited education, family and social support disruption; [6] [7] [8] [9] [10] [11] [12] [13] ). Stigma related to HIV and psychological challenges created by HIV disclosure among sexually active adolescents and young adults contribute to the burden of early life adversities in this vulnerable population [39] .
Previous machine learning studies of brain integrity in people living with HIV have exclusively targeted adult samples [19] [20] [21] . Our study is the first to establish a machine learning classifier of neurocognitive performance in children with pHIV. Our GBM approach differentiated individuals designated as neurocognitively resilient vs. at risk. Unlike studies in adult samples [21] , we focused on children without evidence of severe neurocognitive impairment and without a history of brain trauma. Differentiation of individuals with less severe neurocognitive impairment from normative performance requires analytic methods capable of integrating more input variables than what can be achieved with traditional statistics. Results from this study underscore this point, as the machine learning algorithm performed more than two-fold better than logistic regression in classifying individuals with divergent neurocognitive outcomes. Our decision to include individuals without overt neurocognitive impairment is consistent with work in other populations in which predictive modeling targets the prodromal stages of neurocognitive dysfunction [40] [41] . Early detection of neurocognitive risk is especially important for pediatric populations who can benefit from informed educational/therapeutic services.
Our set of input features included a broad range of typical (e.g., means, max), and less common (minimum percent change) metrics without a priori bias as to which variables were most relevant to the outcomes. Interestingly, only one predictive feature (baseline triglyceride level) was defined by a typical average value; all other predictors represented change (i.e., temporal patterns) or dispersion metrics. The poor sensitivity of average values was borne out by the logistic regression model and by the between-group contrasts from the first and last visits, neither of which identified a consistent profile of risk. By contrast, temporal patterns discovered by the machine learning analysis were salient predictive features, representing 75% of the final algorithm (Supplement Figure 2) . These findings reinforce results from prior studies demonstrating poor stability and generalizability of predictive models built from cross-sectional data [42] [43] [44] . Prospective research is resource-intense and computationally challenging, but longitudinal cohort studies such as PREDICT are necessary to develop accurate longitudinal models (e.g., time series forecasting) of neurodevelopment.
Another important result from this study is the synergy observed between mental and biological markers of health and HIV (e.g., triglyceride levels, erythrocyte count, viral load, CD4 count). Mental health emerged as an important element in 28% of the algorithm (Supplemental Table 1 ). Consistent/stable scores reported on the CBCL Anxiousness, Affective, Somatic
Problems, and Social Competence subscales interacted with higher erythrocyte count, lower triglyceride level, CD4, greater degree of HIV RNA reduction, and higher platelet counts.
Whether the expression of mental health symptoms precedes, follow, or emerges concurrently with change in these biometrics cannot be ascertained from the current study. However, the observation that > 50% of the top 10 classifiers were comprised of multi-level interactions involving mental health emphasize the potential clinical value of synergies across predictors rather than cumulative models of risk stratification.
Interestingly, several polynomial interactions were comprised of composite scores and inter-related subscales (e.g., CBCL Total Score and CBCL Affective scale). While these variables are inherently intertwined, each contribute a degree of explanatory variance in neurocognitive trajectories. Machine learning methods are well suited to examine these interdependencies, albeit this often occurs at the expense of clear relevance to clinical meaning.
Prior work describes the "black box dilemma" [14] of machine learning algorithms that favor classification accuracy over clinical interpretation. Deep learning algorithms, similar to the approach utilized in this study, offer preliminary insights into the underlying mechanisms, but follow-up work with item-level analyses are needed.
Limitations of the study merit discussion. Overfitting is a concern with any predictive model, including data-driven methods such as machine learning. The specific approach utilized in this study is relatively robust to overfitting and other sources of error such as unbalanced group designs, and low base rates of the targeted outcome [14] . Nevertheless, we would expect some loss in predictive accuracy when the algorithm is applied in an independent cohort, particularly since participants enrolled in PREDICT represent a unique group of individuals with pHIV who survived the first year of life without ART. As such, it is unlikely that the algorithm generated for this cohort would apply equally to other populations of pHIV. Finally, as a preliminary study, we explored numerous polynomial interactions and various metrics beyond central measures of tendency. Additional studies are needed to examine the clinical relevance of predictors defined by nontraditional metrics.
In summary, the present study provides a critical first step towards establishing a datadriven predictive model of neurocognitive outcomes in children with pHIV. We cannot fully interpret the clinical relevance of the novel mechanisms identified by the machine learning analysis, but the results provide a compelling argument that mental health interacts with numerous risk factors to govern neurodevelopmental outcomes in children with pHIV. Ideally, these results will guide new data-driven investigations and inform the development of interventions aimed at modifiable risk factors/facilitators of overall health and wellness in children with pHIV. ART: antiretroviral therapy. 
